Suppr超能文献

甲状腺毒症行甲状腺次全切除术后甲状腺碘捕获的行为及其对T3抑制试验的意义。

The behaviour of the thyroidal iodide trap after subtotal thyroidectomy for thyrotoxicosis and its implication for the T3-suppression test.

作者信息

Wilkin T J, Gunn A, Isles T E, Crooks J, Beck J S

出版信息

Acta Endocrinol (Copenh). 1979 Sep;92(1):85-94. doi: 10.1530/acta.0.0920085.

Abstract

It is important to distinguish between symptomatic response and immunological cure in thyrotoxicosis because it has been suggested that surgery, in addition to providing a rapid symptomatic response, may also cause the disappearance of thyroid-stimulating antibodies. The evidence, however, is based largely on suppression tests which we argue may not be valid in the post-operative period. Seventy thyrotoxicosis patients were treated for 6 months with a standard course of carbimazole and T3, at the end of which each patient was classified as suppressor (S) or non-suppressor (NS) according to the fall in radioiodine uptake. Group I (18 patients) and group II (18 patients) were then randomly selected for immediate surgery while group III (34 patients) continued on antithyroid drugs. All groups were reviewed every two months from the 6th month for 12 months, during which time group I was drug-free and groups II and III received T3. Twenty-min iodide uptakes were performed in all patients at each visit to compare the serial changes in mean iodide trapping capacity between treatment groups. Despite 10-fold differences in TSH levels between groups I and II, and irrespective of suppressibility before surgery, the mean uptakes in both these groups remained basal (less than 4%) throughout the period of study, while the serial mean uptakes in group III S (no TSH, by implication no TSAB, but intact iodide trap) were consistently higher than those of group I NS (high TSH, by implication TSAB as well, but reduced iodide trap size). The data points to an absence of dose-responsiveness between TSH and the surgical-remnant's iodide trap, implying that post-thyroidectomy suppression tests (at least during the first year) cannot measure changes in iodide trapping, and therefore do not measure the same phenomenon after subtotal thyroidectomy as they do before operation when the thyroid is intact. We therefore question the validity of comparing suppressibility before and after surgery and basing the frequency of surgical cure on the result.

摘要

区分甲状腺毒症的症状缓解和免疫治愈很重要,因为有人认为手术除了能迅速缓解症状外,还可能导致促甲状腺抗体消失。然而,证据很大程度上基于抑制试验,我们认为这些试验在术后可能无效。70例甲状腺毒症患者接受了为期6个月的卡比马唑和T3标准疗程治疗,疗程结束时,根据放射性碘摄取量的下降情况,将每位患者分为抑制者(S)或非抑制者(NS)。然后随机选择第一组(18例患者)和第二组(18例患者)立即进行手术,而第三组(34例患者)继续使用抗甲状腺药物。从第6个月开始,每两个月对所有组进行一次为期12个月的复查,在此期间,第一组停用药物,第二组和第三组服用T3。每次就诊时对所有患者进行20分钟碘摄取试验,以比较各治疗组之间平均碘摄取能力的系列变化。尽管第一组和第二组之间的促甲状腺激素(TSH)水平相差10倍,且与手术前的抑制性无关,但在整个研究期间,这两组的平均摄取量均保持在基础水平(低于4%),而第三组抑制者(无TSH,意味着无促甲状腺素受体抗体,但碘摄取正常)的系列平均摄取量始终高于第一组非抑制者(高TSH,意味着也有促甲状腺素受体抗体,但碘摄取量降低)。数据表明TSH与手术残余甲状腺的碘摄取之间不存在剂量反应关系,这意味着甲状腺切除术后的抑制试验(至少在第一年)无法测量碘摄取的变化,因此在甲状腺次全切除术后所测量的现象与甲状腺完整时手术前不同。因此,我们质疑比较手术前后抑制性并将手术治愈率频率基于该结果的有效性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验